GLP-1RAs achieve glycemic control through mechanisms such as boosting insulin secretion induced by hyperglycemia, decreasing glucagon secretion during hyperglycemia, slowing gastric emptying, and preventing significant increases in postprandial glucose [43,44]. The gene discussed is GCG; the disease is Hyperglycemia.